zPREDICTA YC 지원서

Summer 2015Acquired

zPREDICTA은(는) Summer 2015 배치에서 Healthcare 회사로 Y Combinator를 거쳤습니다. 아래에는 회사의 사업 내용, 창립자, 그리고 실제 YC 양식에 맞춰 재구성한 YC 지원서가 있습니다.

YC 배치: Summer 2015
산업: HealthcareDrug Discovery and Delivery
팀 규모: 2
상태: Acquired
출시됨: 2015

창업자

Mukti ParikhFounder/CTO

zPREDICTA의 사업 내용

zPREDICTA is developing organ-specific, physiologically-relevant 3D cell culture models providing a 1-to-1 reconstruction of human tissues. This is the only available 3D culture approach that comprehensively accounts for the major components of the cellular and extracellular tissue microenvironment preserving the critical interactions between a tumor and its surroundings. Clinical study data demonstrate the high correlation between drug efficacy measured in our platform and the clinical response. The ability of the zPREDICTA platform to reliably predict clinical outcomes offers superior compound attrition management, empowering researchers to exclude ineffective compounds while selecting agents with a high probability of success in the clinic. Our approach is compatible with any drug class, multiple tissue/cell types and a wide variety of readouts. Our customers are using these models for efficacy screening of anticancer compounds, including immuno-oncology agents, evaluation of mechanisms of drug resistance, the rescue of failed drug candidates, assessment of off-target toxicity, and a multitude other applications.

zPREDICTA의 YC 지원서, 재구성됨

Y Combinator 지원

zPREDICTA, Summer 2015 기수. 공개 데이터를 기반으로 작성된 실제 지원 질문.

Founders2
Company7
Progress7
Idea4
Equity3
Curious2
Batch Preference1

Company

Company name

zPREDICTA

Describe what your company does in 50 characters or less.

Patient-derived 3D tissue models for drug testing

What is your company going to make? Please describe your product and what it does or will do.

We build organ-specific, physiologically relevant 3D cell culture models that reconstruct human tissues on a 1-to-1 scale. Our platform preserves interactions between tumors and their microenvironment, offering a better way to predict drug responses before clinical trials. Researchers use our models to screen anticancer compounds, study drug resistance, and evaluate toxicity.

Where do you live now, and where would the company be based after YC?

We live in San Jose, CA, and plan to keep the company based here after YC.

Explain your decision regarding location.

San Jose is where our labs and early operations are set up, and it's close to the biomedical ecosystem we rely on. Staying here means maintaining easy access to patient samples and collaborators.

전체 지원서에서 21개의 추가 답변

Founders, Progress, Idea, Equity, Curious, Batch Preference는 전체 버전에 있습니다. 무료 계정을 만들어 YC Insights에서 모든 YC 배치 옆에 열어보세요.

전체 지원 보기

자주 묻는 질문

zPREDICTA의 실제 YC 지원서인가요?

아닙니다. Y Combinator는 제출된 지원서를 비공개로 유지합니다. 이것은 재구성된 것입니다. 실제 YC 양식 질문에 zPREDICTA의 공개 데이터(출시 노트, 창업자 배경, 제품 설명)를 기반으로 답변했습니다. zPREDICTA과 같은 회사가 YC에 어떻게 자신을 소개하는지 보여주며, 그들이 제출한 텍스트는 아닙니다.